GB1457382A - Process for preparing live varticella vaccines - Google Patents

Process for preparing live varticella vaccines

Info

Publication number
GB1457382A
GB1457382A GB1007475A GB1007475A GB1457382A GB 1457382 A GB1457382 A GB 1457382A GB 1007475 A GB1007475 A GB 1007475A GB 1007475 A GB1007475 A GB 1007475A GB 1457382 A GB1457382 A GB 1457382A
Authority
GB
United Kingdom
Prior art keywords
varticella
vaccines
varicella
march
preparing live
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1007475A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation for Microbial Diseases of Osaka University BIKEN
Original Assignee
Research Foundation for Microbial Diseases of Osaka University BIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation for Microbial Diseases of Osaka University BIKEN filed Critical Research Foundation for Microbial Diseases of Osaka University BIKEN
Publication of GB1457382A publication Critical patent/GB1457382A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB1007475A 1974-03-12 1975-03-11 Process for preparing live varticella vaccines Expired GB1457382A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2931874A JPS5341202B2 (enExample) 1974-03-12 1974-03-12

Publications (1)

Publication Number Publication Date
GB1457382A true GB1457382A (en) 1976-12-01

Family

ID=12272859

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1007475A Expired GB1457382A (en) 1974-03-12 1975-03-11 Process for preparing live varticella vaccines

Country Status (5)

Country Link
US (1) US3985615A (enExample)
JP (1) JPS5341202B2 (enExample)
BE (1) BE826568A (enExample)
FR (1) FR2263786B1 (enExample)
GB (1) GB1457382A (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2077590A (en) * 1980-01-25 1981-12-23 Wistar Inst Highly attenuated varicella virus vaccine and production thereof
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
NZ220645A (en) * 1986-06-20 1989-10-27 Merck & Co Inc Modified varicella-zoster virus and its cultivation
IL86180A (en) * 1987-05-04 1992-08-18 Merck & Co Inc Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
CZ289574B6 (cs) * 1992-06-04 2002-02-13 Merck And Co., Inc. Způsob výroby ľivé, atenuované vakcíny viru varicella zoster
WO1994002596A1 (en) * 1992-07-17 1994-02-03 Merck & Co., Inc. Method for preventing zoster or alleviating varicella related post-herpetic neuralgia
KR0177323B1 (ko) * 1996-02-16 1999-04-01 성재갑 바이러스 백신 생산에 유용한 사람 이배체 폐세포 및 이를 이용한 수두 백신의 제조방법
DE69729996T2 (de) * 1996-05-15 2005-08-25 The Research Foundation For Microbial Diseases Of Osaka University, Suita Methode zur identifizierung von attenuiertem varicella virus vom stamm oka oder von einem davon abstammenden stamm
US6051238A (en) * 1996-12-20 2000-04-18 Merck & Co., Inc. Stabilizers for lyophilized mumps vaccines
GB9804632D0 (en) 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
EP1074624B1 (en) * 1999-02-25 2005-04-13 The Research Foundation for Microbial Diseases of Osaka University Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene
US6528066B1 (en) * 1999-09-14 2003-03-04 University Of Iowa Research Foundation Variant varicella-zoster viruses and methods of use
AU2003295398A1 (en) * 2002-11-05 2004-06-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Safer attenuated virus vaccines with missing or diminished latency of infection
US8916175B2 (en) * 2004-06-29 2014-12-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection
US7344839B2 (en) * 2004-12-23 2008-03-18 Aurx, Inc. Virus preparations and methods
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
US10166285B2 (en) 2006-11-09 2019-01-01 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Recombinant virus with diminished latency and methods of using same
KR101154276B1 (ko) 2006-11-17 2012-07-10 사이단호진한다이비세이부쯔뵤우겐큐우카이 신경 신장 촉진제 및 신장 억제제
CN101967466A (zh) 2009-07-28 2011-02-09 新泽西医学院 Orf7缺陷型水痘病毒株、含有该毒株的疫苗及其应用
UA112970C2 (uk) 2010-08-05 2016-11-25 Мерк Шарп Енд Доме Корп. Інактивований вірус вітряної віспи, спосіб його одержання і застосування
CA2829774C (en) 2011-03-14 2019-09-24 National Research Council Of Canada Method of viral production in cells
WO2014043189A1 (en) 2012-09-14 2014-03-20 The Regents Of The University Of Colorado, A Body Corporate Conditionally replication deficient herpes viruses and use thereof in vaccines
SG10202012205XA (en) 2015-11-06 2021-01-28 Adjuvance Technologies Inc Triterpene saponin analogues
IL292991A (en) 2017-04-25 2022-07-01 Adjuvance Tech Inc Triterpene saponin analogs

Also Published As

Publication number Publication date
JPS50123817A (enExample) 1975-09-29
FR2263786B1 (enExample) 1978-12-01
JPS5341202B2 (enExample) 1978-11-01
FR2263786A1 (enExample) 1975-10-10
US3985615A (en) 1976-10-12
BE826568A (fr) 1975-09-12

Similar Documents

Publication Publication Date Title
GB1457382A (en) Process for preparing live varticella vaccines
GB1531762A (en) Cancer antigen cancer therapy and cancer diagnosis
GB1501724A (en) Highly attenuated cytomegalovirus vaccine and production thereof
GB1422973A (en) Process for preparing adsorbed vaccines
JPS5527178A (en) Live influenza virus vaccine
ES466359A1 (es) Procedimiento para preparar vacunas vivas e inactivas del virus de la rabia.
ES8107025A1 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
CA934295A (en) Vaccine for immunization of poultry against marek's disease
ES421549A1 (es) Un procedimiento para preparar una vacuna de virus vivos para las vias respiratorias de ganado bovino.
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
GB1488800A (en) Influenza vaccines
GB1290141A (enExample)
YU311779A (en) Process for preparing vaccines against the virus of early summer meningoencephalitis
DE3064590D1 (en) Process for the preparation of influenza a virus vaccinating strains, vaccinating strain and vaccine containing it
GB1466633A (en) Method for immunizing nursing piglets against transmissible gastroenteritis -tge- virus
GB1462545A (en) Feline rhinotracheitis vaccine and production thereof
GB1358321A (en) Method od tissue cell culture
DE2962921D1 (en) Feline infectious peritonitis vaccine and process for its preparation
SE8201128L (sv) Forfarande for reproduktion av virulent treponema pallidum i vevnadsk ultur
GB1436323A (en) Cell and virus culture systems
SE8205247L (sv) Fiskvacciner
GB1293310A (en) Vaccine
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
GB1498821A (en) Vaccines
DE2960853D1 (en) Intra-respiratory vaccine, modified bacteria strain used in it, vaccine dose form and process for preparing it

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years

Effective date: 19950310